Technical Data
H2005-02
Hepatocyte Growth Factor, Recombinant, Human (HGF, Scatter Factor, SF, Hepatopoietin A)
2ug
10ug
10ug
|
Technical Data |
|
H2005-02 |
Hepatocyte Growth Factor, Recombinant, Human (HGF, Scatter Factor, SF, Hepatopoietin A) |
2ug 10ug |
| Growth Factors, Cytokines | Storage: -20°CShipping: RT |
|
Hepatocyte Growth Factor (HGF) is a multifunctional growth factor which regulates both cell growth and cell motility. It exerts a strong mitogenic effect on hepatocytes and primary epithelial cells. HGF synergizes with Interleukin-3 and GM-CSF to stimulate colony formation of hematopoietic progenitor cells in vitro. It may modulate hematopoiesis. Recombinant Human HGF is a heterodimer, non-glycosylated, polypeptide chain consisting an alpha-chain of 463aa and beta-chain of 234aa having a total molecular mass of 80kD. Sequence: Agrees with the seqeunce of native human HGF. Endotoxin: 0.1ng/ug (IEU/ug) of HGF. Dimers and Aggregates: < 1% as determined by silver-stained SDS-PAGE gel analysis. Biological Activity: Hepatocyte Growth Factor is fully biologically active when compared to standards. The ED50, calculated by the dose-dependent proliferation of monkey 4MBr-5 indicator cells, was found to be 20-40ng/ml. Protein Content: Protein quantitation was carried out by two independent methods: 1. UV spectroscopy at 280nm using the absorbency value of 1.83 as the extinction coefficient for a 0.1% (1mg/ml) solution. This value is calculated by the PC GENE computer analysis program of protein sequences (IntelliGenetics). 2. Analysis by RP-HPLC, using a standard solution of HGF as a Reference Standard. Storage and Stability: Lyophilized powder may be stored at 4°C for short-term only. Reconstitute to nominal volume by adding sterile dH2O, 0.1% HSA or BSA. Aliquot and store at -20°C. Reconstituted product is stable for 24 months at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer. |
Source: Human, recombinant protein expressed by Baculovirus Infected High-5 cells Purity: 98% by by RP-HPLC, FPLC, or reducing/non-reducing SDS-PAGE Silver Stain. Chromatographically purified. Endotoxin: < 0.1ng/ug (IEU/ug). Form: Supplied as a lyophilized powder. Reconstitute in sterile dH2O, 0.1% HSA or BSA to a concentration > 0.1mg/ml. Can be further diluted to other aqueous solutions. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
1. Jinnin, M., Ihn, H., Mimura, Y., Asano, Y., Yamane, K., Tamaki, K.: Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets1 and Fli1. Nucleic Acids Res. 33(11): 3540-9 (2005, Jun 21). 2. Moriyama, M., Matsumura, H., Watanabe, A., Oshiro, S., Aoki, H., Shimizu, T., Nakai, K., Yamagami, H., Kaneko, M., Shioda, A., Tanaka, N., Arakawa, Y.: Evaluation of serum concentrations of human hepatocyte growth factor during interferon therapy for chronic hepatitis C. Intervirology 48(4): 223-9 (2005, Jul-Aug). 3. Mizuno, S., Nakamura, T.: Prevention of neutrophil extravasation by hepatocyte growth factor leads to attenuations of tubular apoptosis and renal dysfunction in mouse ischemic kidneys. Am. J. Pathol. 166(6): 1895-905 (2005, Jun). 4. Chen, Y., Kobayashi, N., Suzuki, S., Soto-Gutierrez, A., Rivas-Carrillo, J.D., Tanaka, K., Navarro-Alvarez, N., Fukazawa, T., Narushima, M., Miki, A., Okitsu, T., Amemiya, H., Tanaka, N.: Transplantation of human hepatocytes cultured with deleted variant of hepatocyte growth factor prolongs the survival of mice with acute liver failure. Transplantation 79(10): 1378-85 (2005, May 27). 5. Ohda, Y., Hori, K., Tomita, T., Hida, N., Kosaka, T., Fukuda, Y., Miwa, H., Matsumoto, T.: Effects of hepatocyte growth factor on rat inflammatory bowel disease models. Dig. Dis. Sci. 50(5): 914-21 (2005, May). 6. Numata, M., Ido, A., Moriuchi, A., Kim, I., Tahara, Y., Yamamoto, S., Hasuike, S., Nagata, K., Miyata, Y., Uto, H., Tsubouchi, H.: Hepatocyte growth factor facilitates the repair of large colonic ulcers in 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats. Inflamm Bowel Dis. 11(6): 551-8 (2005, Jun).
|
||